Sandbox:Mydah: Difference between revisions

Jump to navigation Jump to search
No edit summary
 
(229 intermediate revisions by 3 users not shown)
Line 1: Line 1:
{{MSJ}}
__NOTOC__
==Tuberculosis==
 
{{AE}} {{MSJ}}
==Dysentery in adults resident survival guide==
===Overview===
===Overview===
Tuberculosis is caused by inhalation of bacteria named Mycobacterium tuberculosis. It causes pulmonary and disseminated infection. In the lungs, it cause cavitary lesions in the upper and posterior lobe. It can cause disseminated infection in the brain, lymph nodes, and gastrointestinal tract. It presents with chronic productive cough with purulent phlegm which may contain blood. The patient also presents with systemic symptoms like night sweats, low-grade fever, and significant weight loss. As of 2018 one quarter of the world's population is thought to have latent infection with TB. New infections occur in about 1% of the population each year. In 2018, there were more than 10 million cases of active TB which resulted in 1.5 million deaths. Tuberculosis causes second highest number of deaths from an infectious disease.
[[Dysentery]] is described as [[blood]] with [[Human feces|stools]]. It occurs due to inflammatory reaction causing damage to the [[Gastrointestinal tract|intestinal tract]]. The patient also has a [[fever]], abdominal cramping, discomfort, increased [[Intestine|bowel]] movements, fecal urgency, and [[tenesmus]]. The underlying cause is mostly an infection due to [[bacteria]]. The main aim of the [[physician]] is to assess the severity of gastrointestinal symptoms, [[dehydration]], and [[hypovolemia]]. In [[patient|patients]] with severe symptoms, prompt investigations, and treatment should be carried out to reduce morbidity. This section provides a short and straight to the point overview of the [[dysentery]] in adults.
===Historical Prespective===
 
*TB in humans can be traced back to 9,000 years ago in Atlit Yam, a city now under the Mediterranean Sea, off the coast of Israel.
*Mycobacterium tuberculosis was discovered on March 24, 1882 by Dr. Robert Koch.
===Classification===
*Latent tuberculosis
*Active tuberculosis
** Pulmonary infection
** Extrapulmonary infection
===Pathophysiology===
When people with active pulmonary TB cough, sneeze, speak, sing, or spit, they expel infectious aerosol droplets 0.5 to 5.0 µm in diameter. A single sneeze can release up to 40,000 droplets. Each one of these droplets may transmit the disease, since the infectious dose of tuberculosis is very small (the inhalation of fewer than 10 bacteria may cause an infection).
About 90% of those infected with M. tuberculosis have asymptomatic, latent TB infections (sometimes called LTBI), with only a 10% lifetime chance that the latent infection will progress to overt, active tuberculous disease. TB infection begins when the mycobacteria reach the alveolar air sacs of the lungs, where they invade and replicate within endosomes of alveolar macrophages. Macrophages identify the bacterium as foreign and attempt to eliminate it by phagocytosis.
The primary site of infection in the lungs, known as the "Ghon focus", is generally located in either the upper part of the lower lobe or the lower part of the upper lobe. Tuberculosis of the lungs may also occur via infection from the bloodstream. This is known as a Simon focus and is typically found in the top of the lung. This hematogenous transmission can also spread the infection to more distant sites, such as peripheral lymph nodes, the kidneys, the brain, and the bones.
===Causes===
===Causes===
The main cause of TB is Mycobacterium tuberculosis (MTB), a small, aerobic, nonmotile bacillus. The high lipid content of this pathogen accounts for many of its unique clinical characteristics. Mycobacteria stain by acid-fast stain called Ziehl-Neelson stain. Auramine-rhodamine staining and fluorescence microscopy are also used.  
====Life-threatening Causes====
The ''M. tuberculosis'' complex (MTBC) includes four other TB-causing mycobacteria: ''M. bovis, M. africanum, M. canetti, and M. microti''.
Life-threatening causes include conditions that may result in death or permanent disability within 24 hours if left untreated.
===Differntiating tuberculosis from other diseases===
 
Pulmonary tuberculosis must be differentiated from other diseases that cause productive cough and systemic symptoms like brucellosis, bronchogenic carcinoma, Hodgkin lymphoma, bacterial pneumonia, sarcoidosis, mycoplasmal pneumonia.
*Does not include any known cause
===Epidemiology and Demographics===
 
Roughly one-quarter of the world's population has been infected with M. tuberculosis, with new infections occurring in about 1% of the population each year. However, most infections with M. tuberculosis do not cause TB disease, and 90–95% of infections remain asymptomatic. In 2012, an estimated 8.6 million chronic cases were active. In 2010, 8.8 million new cases of TB were diagnosed, and 1.20–1.45 million deaths occurred, most of these occurring in developing countries. Of these 1.45 million deaths, about 0.35 million occur in those also infected with HIV.
====Common Causes====
Tuberculosis is the second-most common cause of death from infectious disease (after those due to HIV/AIDS).
*[[Shigellosis]]<ref name="pmid27068718">{{cite journal| author=Riddle MS, DuPont HL, Connor BA| title=ACG Clinical Guideline: Diagnosis, Treatment, and Prevention of Acute Diarrheal Infections in Adults. | journal=Am J Gastroenterol | year= 2016 | volume= 111 | issue= 5 | pages= 602-22 | pmid=27068718 | doi=10.1038/ajg.2016.126 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=27068718  }} </ref>
===Risk Factors===
*[[Escherichia coli enteritis|Shiga toxin-producing E. coli]] (STEC) (eg, E. coli O157:H7) infection
# HIV infection
*[[Amoebiasis|Amebic dysentery]] caused by [[Entamoeba histolytica]]<ref name="pmid27068718">{{cite journal| author=Riddle MS, DuPont HL, Connor BA| title=ACG Clinical Guideline: Diagnosis, Treatment, and Prevention of Acute Diarrheal Infections in Adults. | journal=Am J Gastroenterol | year= 2016 | volume= 111 | issue= 5 | pages= 602-22 | pmid=27068718 | doi=10.1038/ajg.2016.126 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=27068718  }} </ref>
# Impoverish living conditions: Homeless shelters, prisons
*[[Salmonella]] infection
# Chronic lung diseases i.e. Silicosis
*[[Campylobacter]] infection<ref name="pmid27068718">{{cite journal| author=Riddle MS, DuPont HL, Connor BA| title=ACG Clinical Guideline: Diagnosis, Treatment, and Prevention of Acute Diarrheal Infections in Adults. | journal=Am J Gastroenterol | year= 2016 | volume= 111 | issue= 5 | pages= 602-22 | pmid=27068718 | doi=10.1038/ajg.2016.126 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=27068718  }} </ref>
# Medications: immunosuppressants like corticosteroids and TNF alpha inhibitors
*Enteric viruses (eg, [[cytomegalovirus]] [CMV] or [[adenovirus]])<ref name="pmid29053792">{{cite journal| author=Shane AL, Mody RK, Crump JA, Tarr PI, Steiner TS, Kotloff K | display-authors=etal| title=2017 Infectious Diseases Society of America Clinical Practice Guidelines for the Diagnosis and Management of Infectious Diarrhea. | journal=Clin Infect Dis | year= 2017 | volume= 65 | issue= 12 | pages= e45-e80 | pmid=29053792 | doi=10.1093/cid/cix669 | pmc=5850553 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=29053792  }} </ref>
===Screening===
*[[Inflammatory bowel disease]]
The primary screening method for TB infection (active or latent) is the Mantoux tuberculin skin test with purified protein derivative (PPD). An in vitro blood test based on interferon-gamma release assay (IGRA) with antigens specific for M tuberculosis can also be used to screen for latent TB infection.
*[[Ischemic colitis]]
===Natural History, Complications and Prognosis===
 
Tuberculosis infection can manifest with pulmonary symptoms and if the infection is disseminated, patient can have symptoms in other systems.
===Evaluation===
====Pulmonary====
Shown below is an algorithm summarizing the diagnosis of [[dysentery]] according to the American College of Gastroenterology guidelines.<ref name="pmid29053792">{{cite journal| author=Shane AL, Mody RK, Crump JA, Tarr PI, Steiner TS, Kotloff K | display-authors=etal| title=2017 Infectious Diseases Society of America Clinical Practice Guidelines for the Diagnosis and Management of Infectious Diarrhea. | journal=Clin Infect Dis | year= 2017 | volume= 65 | issue= 12 | pages= e45-e80 | pmid=29053792 | doi=10.1093/cid/cix669 | pmc=5850553 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=29053792  }} </ref><ref name="pmid27068718">{{cite journal| author=Riddle MS, DuPont HL, Connor BA| title=ACG Clinical Guideline: Diagnosis, Treatment, and Prevention of Acute Diarrheal Infections in Adults. | journal=Am J Gastroenterol | year= 2016 | volume= 111 | issue= 5 | pages= 602-22 | pmid=27068718 | doi=10.1038/ajg.2016.126 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=27068718  }} </ref><ref name="pmid14702426">{{cite journal| author=Thielman NM, Guerrant RL| title=Clinical practice. Acute infectious diarrhea. | journal=N Engl J Med | year= 2004 | volume= 350 | issue= 1 | pages= 38-47 | pmid=14702426 | doi=10.1056/NEJMcp031534 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=14702426  }} </ref><ref name="pmid12818275">{{cite journal| author=Kane SV, Sandborn WJ, Rufo PA, Zholudev A, Boone J, Lyerly D | display-authors=etal| title=Fecal lactoferrin is a sensitive and specific marker in identifying intestinal inflammation. | journal=Am J Gastroenterol | year= 2003 | volume= 98 | issue= 6 | pages= 1309-14 | pmid=12818275 | doi=10.1111/j.1572-0241.2003.07458.x | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=12818275  }} </ref>
If a tuberculosis infection does become active, it most commonly involves the lungs (in about 90% of cases). Symptoms may include chest pain and a prolonged cough producing sputum. About 25% of people may not have any symptoms (i.e. they remain "asymptomatic"). Tuberculosis may become a chronic illness and cause extensive scarring in the upper lobes of the lungs. The upper lung lobes are more frequently affected by tuberculosis than the lower ones.
{{Family tree/start}}
====Extrapulmonary====
{{Family tree | | | | A01 | | | |A01= <div style="float: center; text-align: left;">Characterize the symptoms:
In 15–20% of active cases, the infection spreads outside the lungs, causing other kinds of TB. These are collectively denoted as ''extrapulmonary tuberculosis''. Notable extrapulmonary infection sites include the pleura (in tuberculous pleurisy), the central nervous system (in tuberculous meningitis), the lymphatic system (in scrofula of the neck), the genitourinary system (in urogenital tuberculosis), and the bones and joints (in Pott disease of the spine), among others.
* Duration of [[diarrhea]]
====Complications====
* Frequency and consistency of [[Human feces|stools]]
*Acute
* Presence of [[mucus]] and [[blood]] in the [[Human feces|stools]] }}
** Tb-related sepsis
{{Family tree | | | | |!| | | | | }}
*Chronic
{{Family tree | | | | B01 | | | |B01= <div style="float: center; text-align: left;">To evaluate cause ask the following questions:
** Mycetomas developing within residual TB cavities
* Food history
** Impaired pulmonary function
* Occupational exposure (e.g. daycare center, poultry farm)
** Focal neurological deficits
* Exposure to animals (pets, poultry, zoo, turtles)
====Prognosis====
* Recent travel to endemic areas
The prognosis for drug-sensitive tuberculosis is good if the patient is compliant and complete the treatment protocols. The recurrence rate of TB is low (0%-14%) and some may be due to reinfection. Drug-resistant tuberculosis is more difficult to treat, and the prognosis is not as good.
* Medication history (use of [[proton pump inhibitor]] increase susceptibility to [[infection]] with [[Shigella]]) }}
{{Family tree | | | | |!| | | | | }}
{{Family tree | | | | C01 | | | |C01= <div style="float: center; text-align: left;">Does the patient have any of the following clinical signs or history?
* Old age (more than 70 years)
* Presence of co-morbidities (advance [[heart disease]], severe immunocompromised state)
* [[Fever]] (>101.3 degrees Fahrenheit)
* Presence of severe symptoms
* Need for hospitalization
* Signs of [[dehydration]] (dry mucous membranes, sunken [[Eye|eyes]], decreased [[skin]] turgor, [[orthostatic hypotension]], [[oliguria]], dark-colored [[urine]], and [[Somnolence|drowsiness]] )
abdominal tenderness on [[palpation]], [[rebound tenderness]], [[abdominal distention]], and abdominal rigidity. }}
{{Family tree | |,|-|-|^|-|-|-|-|.| | }}
{{Family tree | D01 | | | | | | D02 |D01= Yes |D02= No}}
{{Family tree | |!| | | | | | | |!| | }}
{{Family tree | E01 | | | | | | E02 |E01= <div style="float: center; text-align: left;">Perform the following [[Human feces|stool]] tests:
* Bacterial culture for [[Salmonella]], [[Shigella]], and [[Campylobacter]].
* Test for [[Shigella]] toxin and [[Escherichia coli|E. coli]] O157: H7
* Test for fecal [[leukocytes]] and [[lactoferrin]]. |E02= <div style="float: center; text-align: left;">Does the patient have any of the following:
* Clinical signs suggestive of [[inflammatory bowel disease]]
* Symptoms present for more than a week despite conservative management
* The patient is a health care worker or food handler (which can be a potential health hazard) }}
{{Family tree | |!| | | | | |,|-|^|-|.| }}
{{Family tree | F01 | | | | |F02| |F03| |F01= Is the fecal [[leukocytes]] or [[lactoferrin]] test positive? |F02= Yes |F03= No }}
{{Family tree |,|-|^|-|.| | | |!| | | |!| }}
{{Family tree |G01| |G02| |G03| |G04| G01=Yes |G02= No |G03=  
* Perform routine [[Human feces|stool]] culture.
* Specific tests should be performed depending upon the patient’s history. |G04= No need to perform [[Human feces|Stool]] culture and additional tests. }}
{{Family tree |!| | | |!| | | }}
{{Family tree |F01| |F02| |F01= Test for [[Entamoeba histolytica]] |F02= [[Amoebiasis|Amebic dysentery]] highly unlikely. Look for other causative agents. }}
 
===Treatment===
===Treatment===
====Latent====
Shown below is an algorithm summarizing the treatment of [[dysentery]] according to the Infectious Diseases Society of America clinical practice guidelines.<ref name="pmid27068718">{{cite journal| author=Riddle MS, DuPont HL, Connor BA| title=ACG Clinical Guideline: Diagnosis, Treatment, and Prevention of Acute Diarrheal Infections in Adults. | journal=Am J Gastroenterol | year= 2016 | volume= 111 | issue= 5 | pages= 602-22 | pmid=27068718 | doi=10.1038/ajg.2016.126 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=27068718  }} </ref><ref name="pmid11100619">{{cite journal| author=Victora CG, Bryce J, Fontaine O, Monasch R| title=Reducing deaths from diarrhoea through oral rehydration therapy. | journal=Bull World Health Organ | year= 2000 | volume= 78 | issue= 10 | pages= 1246-55 | pmid=11100619 | doi= | pmc=2560623 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=11100619  }} </ref><ref name="pmid20687081">{{cite journal| author=Christopher PR, David KV, John SM, Sankarapandian V| title=Antibiotic therapy for Shigella dysentery. | journal=Cochrane Database Syst Rev | year= 2010 | volume= | issue= 8 | pages= CD006784 | pmid=20687081 | doi=10.1002/14651858.CD006784.pub4 | pmc=6532574 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=20687081  }} </ref>
Latent tuberculosis is treated with either Isoniazid alone or both Isoniazid and Rifampicin given for three to nine months.
{{familytree/start }}
====Active====
{{familytree | | | | | | | | A01 |A01= <div style="float: center; text-align: left;">Characterize the symptoms of the [[patient]]:
* Presence of severe [[diarrhea]] along with systemic symptoms.
* Two or more clinical signs for [[dehydration]] (i.e. Sunken [[Eye|eyes]], dry [[mucous membrane]], reduced [[skin]] turgor, increased [[thirst]] ). }}
{{familytree | | | | |,|-|-|-|^|-|-|-|-|.| | | }}
{{familytree | | | B01 | | | | | | | | B02 | | |B01= Yes |B02= No }}
{{familytree | | | |!| | | | | | | | | |!| | | }}
{{familytree | | | C01 | | | | | | | | C02 | | |C01= <div style="float: left; text-align: left;">
* [[Fluid replacement]] therapy.
* Empirical [[Antibiotic|antibiotics]] therapy.
* The drug of choice is [[Quinolone|fluoroquinolones]] (500mg [[Levofloxacin (oral)]] once daily for 3 days).  If the symptoms do not improve in a few days, the patient should be switched to either [[azithromycin (oral)]] or [[cephalosporin]].
* Bismuth sulphate and [[loperamide]] to relieve abdominal cramps and discomfort. |C02= <div style="float: left; text-align: left;">
* Oral [[fluid replacement]] therapy. Give [[Oral rehydration therapy|ORS]] solution for every [[Intestine|bowel]] movement. Approximately 2 liters of [[Oral rehydration therapy|ORS]] solution is given to the [[patient]].
* Antimicrobial therapy should be initiated on the basis of [[Human feces|stool]] culture results.
* Bismuth sulphate and [[loperamide]] can be given to relieve abdominal symptoms.
* Reassess hydration status after every 6 hours. }}
{{familytree | | | |!| | | | | | | | }}
{{familytree | | | D01 | | | | | | |D01= Assess [[patient]] for symptoms of [[hypovolemia]] (i.e. [[altered mental status]] with [[lethargy]] and [[unconsciousness]], weak [[Pulse|pulses]] , and inability to drink) }}
{{familytree | |,|-|^|.| | | | }}
{{familytree | D01 | | D02 | |D01= Yes |D02= No }}
{{familytree | |!| | | |!| | | }}
{{familytree | E01 | | E02 | |E01= <div style="float: left; text-align: left;">Patient has severe [[hypovolemia]].
* Give [[Intravenous therapy|parenteral]] [[fluid replacement]] with 5 % dextrose or [[Saline (medicine)|normal saline]] solution.
* Give rapid infusion initially and then slow infusion.
* The aim is to give 200 ml/kg in 24 hours with 100ml/kg in the first 4 hours of infusion.
* Reassess [[Hemodynamics|hemodynamic]] and hydration status of the [[patient]] after 6 hours. |E02= <div style="float: left; text-align: left;"> [[Patient]] has mild [[hypovolemia]].
* Give oral [[fluid replacement]] therapy.
* 2.2 to 4 liters of [[Oral rehydration therapy|ORS]] is given in the first 4 hours.
* Reassess [[Hemodynamics|hemodynamic]] and hydration status of the [[patient]] after 6 hours. }}
{{familytree/end}}
 
===Do's===
* Important clues regarding the etiology of dysentery can be narrowed down while taking history. If the patient has dysentery more than 16 hours after having an outdoor food consider [[Enterotoxigenic Escherichia coli|Enterotoxigenic ''E.coli'']]. There is an increased risk of acquiring the [[''Salmonella'']] infection in individuals exposed to turtles and poultry. People working in daycare have an increased risk of infection with enteric [[Virus|viruses]] and [[''Shigella'']].<ref name="pmid27068718">{{cite journal| author=Riddle MS, DuPont HL, Connor BA| title=ACG Clinical Guideline: Diagnosis, Treatment, and Prevention of Acute Diarrheal Infections in Adults. | journal=Am J Gastroenterol | year= 2016 | volume= 111 | issue= 5 | pages= 602-22 | pmid=27068718 | doi=10.1038/ajg.2016.126 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=27068718  }} </ref>
* Physicians can take a rectal swab in patients in whom stool samples cannot be obtained and immediate diagnosis is required.<ref name="pmid30944186">{{cite journal| author=Jean S, Yarbrough ML, Anderson NW, Burnham CA| title=Culture of Rectal Swab Specimens for Enteric Bacterial Pathogens Decreases Time to Test Result While Preserving Assay Sensitivity Compared to Bulk Fecal Specimens. | journal=J Clin Microbiol | year= 2019 | volume= 57 | issue= 6 | pages=  | pmid=30944186 | doi=10.1128/JCM.02077-18 | pmc=6535583 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=30944186  }} </ref> Though the rectal swab has less sensitivity than [[Human feces|stool]] culture in identifying the causative agent.<ref name="pmid30315956">{{cite journal| author=Kotar T, Pirš M, Steyer A, Cerar T, Šoba B, Skvarc M | display-authors=etal| title=Evaluation of rectal swab use for the determination of enteric pathogens: a prospective study of diarrhoea in adults. | journal=Clin Microbiol Infect | year= 2019 | volume= 25 | issue= 6 | pages= 733-738 | pmid=30315956 | doi=10.1016/j.cmi.2018.09.026 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=30315956  }} </ref>
* If the clinician is suspecting a particular [[bacteria]], it should be mentioned while ordering the test. Certain [[bacteria]] require special culture media to grow and methods to be visualized. [[''Campylobacter jejuni'']] grows on the specific ‘CAMP’ agar plates at a particular temperature and environmental conditions. If infection with [[''Yersinia'']] is suspected, it should be specified as it is commonly overlooked.<ref name="pmid4014291">{{cite journal| author=Guerrant RL, Shields DS, Thorson SM, Schorling JB, Gröschel DH| title=Evaluation and diagnosis of acute infectious diarrhea. | journal=Am J Med | year= 1985 | volume= 78 | issue= 6B | pages= 91-8 | pmid=4014291 | doi=10.1016/0002-9343(85)90370-5 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=4014291  }} </ref>
* Physicians need to monitor the patients for the complications of the infection with certain [[bacteria]].  [[Bacteremia]] and [[reactive arthritis]] can occur with infection with non- typhoidal [[''Salmonella'']] and [[''Shigella'']].<ref name="pmid16621698">{{cite journal| author=Rodríguez M, de Diego I, Martínez N, Rosario Rodicio M, Carmen Mendoza M| title=Nontyphoidal Salmonella causing focal infections in patients admitted at a Spanish general hospital during an 11-year period (1991-2001). | journal=Int J Med Microbiol | year= 2006 | volume= 296 | issue= 4-5 | pages= 211-22 | pmid=16621698 | doi=10.1016/j.ijmm.2006.01.068 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=16621698  }} </ref> The [[hemolytic-uremic syndrome]] can occur due to E 0157:H7 or [[''Shigella'']]. A neurological complication [[Guillain-Barré syndrome]] can occur with [[''Campylobacter'']] infection.
===Don'ts===
* The empirical antimicrobial [[treatment]] for [[dysentery]] does not include [[treatment]] for [[Entamoeba histolytica|''E. histolytica'']].  [[Metronidazole]] (500mg thrice daily for 7 to days) should be administered to [[patient|patients]] only when trophozoites or cysts are visualized under a [[microscope]] in the [[Human feces|stool]] sample.<ref name="pmid590600">{{cite journal| author=Misra NP, Gupta RC| title=A comparison of a short course of single daily dosage therapy of tinidazole with metronidazole in intestinal amoebiasis. | journal=J Int Med Res | year= 1977 | volume= 5 | issue= 6 | pages= 434-7 | pmid=590600 | doi=10.1177/030006057300100209 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=590600  }} </ref>
* A complete metabolic profile is not routinely performed in [[patient|patients]] with [[dysentery]]. [[Serum]] electrolytes and [[glucose]] levels should only be measured in [[patient|patients]] who present with complications (i.e. [[altered mental status]], [[Seizure|seizures]], [[anuria]], [[oliguria]], and [[ileus]] ).
 
==References==
{{Reflist}}

Latest revision as of 22:10, 26 August 2020


Associate Editor(s)-in-Chief: Mydah Sajid, MD[1]

Dysentery in adults resident survival guide

Overview

Dysentery is described as blood with stools. It occurs due to inflammatory reaction causing damage to the intestinal tract. The patient also has a fever, abdominal cramping, discomfort, increased bowel movements, fecal urgency, and tenesmus. The underlying cause is mostly an infection due to bacteria. The main aim of the physician is to assess the severity of gastrointestinal symptoms, dehydration, and hypovolemia. In patients with severe symptoms, prompt investigations, and treatment should be carried out to reduce morbidity. This section provides a short and straight to the point overview of the dysentery in adults.

Causes

Life-threatening Causes

Life-threatening causes include conditions that may result in death or permanent disability within 24 hours if left untreated.

  • Does not include any known cause

Common Causes

Evaluation

Shown below is an algorithm summarizing the diagnosis of dysentery according to the American College of Gastroenterology guidelines.[2][1][3][4]

Treatment

Shown below is an algorithm summarizing the treatment of dysentery according to the Infectious Diseases Society of America clinical practice guidelines.[1][5][6]

 
 
 
Characterize the symptoms:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
To evaluate cause ask the following questions:
  • Food history
  • Occupational exposure (e.g. daycare center, poultry farm)
  • Exposure to animals (pets, poultry, zoo, turtles)
  • Recent travel to endemic areas
  • Medication history (use of proton pump inhibitor increase susceptibility to infection with Shigella)
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Does the patient have any of the following clinical signs or history? abdominal tenderness on palpation, rebound tenderness, abdominal distention, and abdominal rigidity.
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Yes
 
 
 
 
 
No
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Perform the following stool tests:
 
 
 
 
 
Does the patient have any of the following:
  • Clinical signs suggestive of inflammatory bowel disease
  • Symptoms present for more than a week despite conservative management
  • The patient is a health care worker or food handler (which can be a potential health hazard)
  •  
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
    Is the fecal leukocytes or lactoferrin test positive?
     
     
     
     
    Yes
     
    No
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
    Yes
     
    No
     
    * Perform routine stool culture.
    • Specific tests should be performed depending upon the patient’s history.
     
    No need to perform Stool culture and additional tests.
     
     
     
     
     
     
     
     
     
     
    Test for Entamoeba histolytica
     
    Amebic dysentery highly unlikely. Look for other causative agents.
     
     
     
     
     
     
     
     
    Characterize the symptoms of the patient:
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
    Yes
     
     
     
     
     
     
     
    No
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
  • Oral fluid replacement therapy. Give ORS solution for every bowel movement. Approximately 2 liters of ORS solution is given to the patient.
  • Antimicrobial therapy should be initiated on the basis of stool culture results.
  • Bismuth sulphate and loperamide can be given to relieve abdominal symptoms.
  • Reassess hydration status after every 6 hours.
  •  
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
    Assess patient for symptoms of hypovolemia (i.e. altered mental status with lethargy and unconsciousness, weak pulses , and inability to drink)
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
    Yes
     
    No
     
     
     
     
     
     
     
     
     
     
     
     
    Patient has severe hypovolemia.
    • Give parenteral fluid replacement with 5 % dextrose or normal saline solution.
    • Give rapid infusion initially and then slow infusion.
    • The aim is to give 200 ml/kg in 24 hours with 100ml/kg in the first 4 hours of infusion.
    • Reassess hemodynamic and hydration status of the patient after 6 hours.
     
    Patient has mild hypovolemia.
  • Give oral fluid replacement therapy.
  • 2.2 to 4 liters of ORS is given in the first 4 hours.
  • Reassess hemodynamic and hydration status of the patient after 6 hours.
  •  

    Do's

    • Important clues regarding the etiology of dysentery can be narrowed down while taking history. If the patient has dysentery more than 16 hours after having an outdoor food consider Enterotoxigenic E.coli. There is an increased risk of acquiring the ''Salmonella'' infection in individuals exposed to turtles and poultry. People working in daycare have an increased risk of infection with enteric viruses and ''Shigella''.[1]
    • Physicians can take a rectal swab in patients in whom stool samples cannot be obtained and immediate diagnosis is required.[7] Though the rectal swab has less sensitivity than stool culture in identifying the causative agent.[8]
    • If the clinician is suspecting a particular bacteria, it should be mentioned while ordering the test. Certain bacteria require special culture media to grow and methods to be visualized. ''Campylobacter jejuni'' grows on the specific ‘CAMP’ agar plates at a particular temperature and environmental conditions. If infection with ''Yersinia'' is suspected, it should be specified as it is commonly overlooked.[9]
    • Physicians need to monitor the patients for the complications of the infection with certain bacteria. Bacteremia and reactive arthritis can occur with infection with non- typhoidal ''Salmonella'' and ''Shigella''.[10] The hemolytic-uremic syndrome can occur due to E 0157:H7 or ''Shigella''. A neurological complication Guillain-Barré syndrome can occur with ''Campylobacter'' infection.

    Don'ts

    References

    1. 1.0 1.1 1.2 1.3 1.4 1.5 Riddle MS, DuPont HL, Connor BA (2016). "ACG Clinical Guideline: Diagnosis, Treatment, and Prevention of Acute Diarrheal Infections in Adults". Am J Gastroenterol. 111 (5): 602–22. doi:10.1038/ajg.2016.126. PMID 27068718.
    2. 2.0 2.1 Shane AL, Mody RK, Crump JA, Tarr PI, Steiner TS, Kotloff K; et al. (2017). "2017 Infectious Diseases Society of America Clinical Practice Guidelines for the Diagnosis and Management of Infectious Diarrhea". Clin Infect Dis. 65 (12): e45–e80. doi:10.1093/cid/cix669. PMC 5850553. PMID 29053792.
    3. Thielman NM, Guerrant RL (2004). "Clinical practice. Acute infectious diarrhea". N Engl J Med. 350 (1): 38–47. doi:10.1056/NEJMcp031534. PMID 14702426.
    4. Kane SV, Sandborn WJ, Rufo PA, Zholudev A, Boone J, Lyerly D; et al. (2003). "Fecal lactoferrin is a sensitive and specific marker in identifying intestinal inflammation". Am J Gastroenterol. 98 (6): 1309–14. doi:10.1111/j.1572-0241.2003.07458.x. PMID 12818275.
    5. Victora CG, Bryce J, Fontaine O, Monasch R (2000). "Reducing deaths from diarrhoea through oral rehydration therapy". Bull World Health Organ. 78 (10): 1246–55. PMC 2560623. PMID 11100619.
    6. Christopher PR, David KV, John SM, Sankarapandian V (2010). "Antibiotic therapy for Shigella dysentery". Cochrane Database Syst Rev (8): CD006784. doi:10.1002/14651858.CD006784.pub4. PMC 6532574 Check |pmc= value (help). PMID 20687081.
    7. Jean S, Yarbrough ML, Anderson NW, Burnham CA (2019). "Culture of Rectal Swab Specimens for Enteric Bacterial Pathogens Decreases Time to Test Result While Preserving Assay Sensitivity Compared to Bulk Fecal Specimens". J Clin Microbiol. 57 (6). doi:10.1128/JCM.02077-18. PMC 6535583 Check |pmc= value (help). PMID 30944186.
    8. Kotar T, Pirš M, Steyer A, Cerar T, Šoba B, Skvarc M; et al. (2019). "Evaluation of rectal swab use for the determination of enteric pathogens: a prospective study of diarrhoea in adults". Clin Microbiol Infect. 25 (6): 733–738. doi:10.1016/j.cmi.2018.09.026. PMID 30315956.
    9. Guerrant RL, Shields DS, Thorson SM, Schorling JB, Gröschel DH (1985). "Evaluation and diagnosis of acute infectious diarrhea". Am J Med. 78 (6B): 91–8. doi:10.1016/0002-9343(85)90370-5. PMID 4014291.
    10. Rodríguez M, de Diego I, Martínez N, Rosario Rodicio M, Carmen Mendoza M (2006). "Nontyphoidal Salmonella causing focal infections in patients admitted at a Spanish general hospital during an 11-year period (1991-2001)". Int J Med Microbiol. 296 (4–5): 211–22. doi:10.1016/j.ijmm.2006.01.068. PMID 16621698.
    11. Misra NP, Gupta RC (1977). "A comparison of a short course of single daily dosage therapy of tinidazole with metronidazole in intestinal amoebiasis". J Int Med Res. 5 (6): 434–7. doi:10.1177/030006057300100209. PMID 590600.